Quick Answer
IceCure Medical Ltd. reported Cash and Equivalents of $8.90 million for fiscal year 2025.
IceCure Medical Ltd. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $8.90M | +17.6% |
| 2024 | $7.56M | -28.2% |
| 2023 | $10.53M | -55.5% |
| 2022 | $23.66M | -7.7% |
| 2021 | $25.62M | +631.6% |
| 2020 | $3.50M | — |
- IceCure Medical Ltd. showed an increase of +17.6% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2020–2025 period, IceCure Medical Ltd.’s cash and equivalents has grown by 154.1% (from $3.50 million to $8.90 million).
- The most recent figure is from IceCure Medical Ltd.’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: